Yigang Zuo

Kunming, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Covered Metal Ureteral Stents in the Maintenance Treatment of Refractory Ureteral Stricture: A Prospective, Multi-Center, and Large-Scale Cohort Study with 3-Year Outcomes.

Covered Metal Ureteral Stents in the Maintenance Treatment of Refractory Ureteral Stricture: A Prospective, Multi-Center, and Large-Scale Cohort Study with 3-Year Outcomes.

Journal: Journal of endourology

Published: September 12, 2025

Comparison of the efficacy and safety of mini-percutaneous nephrolithotomy versus retrograde intrarenal surgery for the treatment of kidney stones in overweight or obese patients: a systematic review and meta-analysis.

Comparison of the efficacy and safety of mini-percutaneous nephrolithotomy versus retrograde intrarenal surgery for the treatment of kidney stones in overweight or obese patients: a systematic review and meta-analysis.

Journal: BMC urology

Published: April 01, 2024

Bronchiolar adenoma/ciliated muconodular papillary tumour: advancing clinical, pathological, and imaging insights for future perspectives.

Bronchiolar adenoma/ciliated muconodular papillary tumour: advancing clinical, pathological, and imaging insights for future perspectives.

Journal: Clinical radiology

Published: September 04, 2023

Long Noncoding RNA HAGLROS Promotes the Malignant Progression of Bladder Cancer by Regulating the miR-330-5p/SPRR1B Axis.

Long Noncoding RNA HAGLROS Promotes the Malignant Progression of Bladder Cancer by Regulating the miR-330-5p/SPRR1B Axis.

Journal: Frontiers in oncology

Published: February 15, 2022

Erratum: LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.

Erratum: LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.

Journal: Oncology letters

Published: January 24, 2022

HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer.

HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer.

Journal: Frontiers in genetics

Published: October 29, 2021

MicroRNA-20a Targeting LASS2 Promotes the Proliferation, Invasiveness and Migration of Bladder Cancer.

MicroRNA-20a Targeting LASS2 Promotes the Proliferation, Invasiveness and Migration of Bladder Cancer.

Journal: Clinical laboratory

Published: August 12, 2021

Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population.

Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: October 03, 2019

MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.

MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.

Journal: Experimental cell research

Published: August 18, 2018

Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics.

Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics.

Journal: Oncology reports

Published: April 09, 2018

A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro.

A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro.

Journal: Cancer medicine

Published: November 17, 2017

LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.

LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.

Journal: Oncology letters

Published: May 29, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026